Trinity Biotech earnings were -$20.3M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest TRIB earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$4.8M, down 29.6% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, TRIB reported annual earnings of -$24.0M, with -41.4% growth.
What were Trinity Biotech's earnings last quarter?
Trinity Biotech (NASDAQ: TRIB) reported Q3 2024 earnings per share (EPS) of N/A, up N/A year over year. Total TRIB earnings for the quarter were -$4.76 million. In the same quarter last year, Trinity Biotech's earnings per share (EPS) was N/A.
As of the last Trinity Biotech earnings report, Trinity Biotech is currently losing money. Trinity Biotech's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$20.33 million, a 28.89% decrease year over year.
What was TRIB's earnings growth in the past year?
As of Trinity Biotech's earnings date in Q1 2025, Trinity Biotech's earnings has grown year over year. TRIB earnings in the past year totalled -$20.33 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.